Villemagne VL - Search Results

1

Amyloid imaging: Past, present and future perspectives.

Villemagne VL. Villemagne VL. Ageing Res Rev. 2016 Sep;30:95-106. doi: 10.1016/j.arr.2016.01.005. Epub 2016 Jan 28. Ageing Res Rev. 2016. PMID: 26827784 Review.

2

Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease.

Villemagne VL, Rowe CC, Macfarlane S, Novakovic KE, Masters CL. Villemagne VL, et al. J Clin Neurosci. 2005 Apr;12(3):221-30. doi: 10.1016/j.jocn.2004.03.011. J Clin Neurosci. 2005. PMID: 15851069 Review.

3

Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.

Masters CL, Cappai R, Barnham KJ, Villemagne VL. Masters CL, et al. Among authors: villemagne vl. J Neurochem. 2006 Jun;97(6):1700-25. doi: 10.1111/j.1471-4159.2006.03989.x. J Neurochem. 2006. PMID: 16805778 Free article. Review.

4

Imaging beta-amyloid burden in aging and dementia.

Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, Smith C, Woodward M, Merory J, Tochon-Danguy H, O'Keefe G, Klunk WE, Mathis CA, Price JC, Masters CL, Villemagne VL. Rowe CC, et al. Among authors: villemagne vl. Neurology. 2007 May 15;68(20):1718-25. doi: 10.1212/01.wnl.0000261919.22630.ea. Neurology. 2007. PMID: 17502554

5

In vitro characterization of Pittsburgh compound-B binding to Lewy bodies.

Fodero-Tavoletti MT, Smith DP, McLean CA, Adlard PA, Barnham KJ, Foster LE, Leone L, Perez K, Cortés M, Culvenor JG, Li QX, Laughton KM, Rowe CC, Masters CL, Cappai R, Villemagne VL. Fodero-Tavoletti MT, et al. Among authors: villemagne vl. J Neurosci. 2007 Sep 26;27(39):10365-71. doi: 10.1523/JNEUROSCI.0630-07.2007. J Neurosci. 2007. PMID: 17898208 Free PMC article.

6

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC. Pike KE, et al. Among authors: villemagne vl. Brain. 2007 Nov;130(Pt 11):2837-44. doi: 10.1093/brain/awm238. Epub 2007 Oct 10. Brain. 2007. PMID: 17928318

7

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.

Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O'Keefe G, Tochon-Danguy H, Chan G, Berlangieri SU, Jones G, Dickinson-Rowe KL, Kung HP, Zhang W, Kung MP, Skovronsky D, Dyrks T, Holl G, Krause S, Friebe M, Lehman L, Lindemann S, Dinkelborg LM, Masters CL, Villemagne VL. Rowe CC, et al. Among authors: villemagne vl. Lancet Neurol. 2008 Feb;7(2):129-35. doi: 10.1016/S1474-4422(08)70001-2. Epub 2008 Jan 10. Lancet Neurol. 2008. PMID: 18191617

8

The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias.

Villemagne VL, Fodero-Tavoletti MT, Pike KE, Cappai R, Masters CL, Rowe CC. Villemagne VL, et al. Mol Neurobiol. 2008 Aug;38(1):1-15. doi: 10.1007/s12035-008-8019-y. Epub 2008 Aug 9. Mol Neurobiol. 2008. PMID: 18690556 Review.

9

High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types.

Villemagne VL, Ataka S, Mizuno T, Brooks WS, Wada Y, Kondo M, Jones G, Watanabe Y, Mulligan R, Nakagawa M, Miki T, Shimada H, O'Keefe GJ, Masters CL, Mori H, Rowe CC. Villemagne VL, et al. Arch Neurol. 2009 Dec;66(12):1537-44. doi: 10.1001/archneurol.2009.285. Arch Neurol. 2009. PMID: 20008660

10

11C-PiB PET ABri imaging in Worster-Drought syndrome (familial British dementia): a case report.

Villemagne VL, Pike K, Pejoska S, Boyd A, Power M, Jones G, Masters CL, Rowe CC. Villemagne VL, et al. J Alzheimers Dis. 2010;19(2):423-8. doi: 10.3233/JAD-2010-1241. J Alzheimers Dis. 2010. PMID: 20110591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

451 results

Search Page